TP53 and Huntington disease: Even if p53 and p53 activation upregulation are found to promote neurodegeneration as a stand-alone intervention in the presence of mutant huntingtin, they may still constitute therapeutically desirable targets in a multi-drug regimen that addresses other epigenetic disturbances in HD.